[ad_1]
Researchers around the world are looking for ways to successfully treat COVID-19 patients. Coronavirus, which has already infected more than 3.3 million people worldwide. people, forced almost half of humanity to adhere to certain quarantine measures and dealt a severe blow to the global economy.
US authorities approved the use of the antiviral drug remdesivir, designed to treat Ebola virus-infected patients, on Friday, when a major study showed the drug speeds recovery of patients with serious conditions with COVID-19.
“This is certainly a very promising opportunity,” President Donald Trump said at the White House on Friday.
Daniel O’Day, CEO of Gilead Sciences, a biopharmaceutical company that developed remdesivir, also attended the press conference.
The drug works by interfering with the viral genome and blocking its replication.
Recently, US authorities have faced growing dissatisfaction among residents forced to stay home.
The United States, which recorded around 1.1 million With nearly 65,000 deaths from coronavirus deaths and almost 65,000 deaths, the world is leading the way for pandemic victims, making Trump eager to find effective solutions as the number of unemployed in the country reaches tens of millions.
“We hope not to exceed 100,000 deaths, although that is a horrible figure,” Trump said, speaking a little earlier this week about the possibility that the epidemic claimed 60 to 70,000 lives in the country. lives
[ad_2]
